Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Clinical trial NCT01585428 · COMPLETED
Trial details
- NCT number
- NCT01585428
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-13
- Primary completion
- 2016-04-09
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.